Financial targets and dividend policy

Growth targets and dividend policy of Optomed.

Last modified: 23.11.2022


Optomed’s medium-term, from 2020 onwards, target is to deliver a double digit annual organic revenue growth.

In the long-term Optomed’s target is to deliver an average annual organic revenue growth above 20 percent.

Adjusted EBITDA-margin

Optomed’s target in the medium-term is to prioritise investments in the organisation to support growth and achieve an adjusted EBITDA margin above 30% in the long-term.

Dividend policy

Optomed is in expansion phase and will therefore prioritise growth over dividends in coming years.